A complex landscape of state laws overlays the direct access testing model, ranging from physician order requirements, such as telemedicine standards and the corporate practice of medicine doctrine, to specimen collection considerations, including how the varying options for collection could impact a model.
How do these factors combine to create a roadmap for companies navigating the direct access testing industry?
On the third episode of our four-part series on direct See more +
A complex landscape of state laws overlays the direct access testing model, ranging from physician order requirements, such as telemedicine standards and the corporate practice of medicine doctrine, to specimen collection considerations, including how the varying options for collection could impact a model.
How do these factors combine to create a roadmap for companies navigating the direct access testing industry?
On the third episode of our four-part series on direct access laboratory testing, Epstein Becker Green attorneys Bob Hearn, Amy Lerman, and Megan Robertson discuss physician ordering and specimen collection considerations for direct access laboratory testing stakeholders.
Stay tuned for the final episode of our special series on direct access laboratory testing.
Visit our site for related reading links and more: http://www.ebglaw.com/dhc63
The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces. Subscribe on your favorite podcast platform. See less -
